The poster will include clinical data as of an April 4, 2025 data cutoff from the Company's ongoing Phase 1/2 clinical trial evaluating azenosertib in combination with encorafenib and cetuximab in ...

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ's dense tissue to define the margins between malignant and normal tissue. A new study uses DNA origami ...

A collection of images from Imperial College London's photography competition uncovers the visual splendor of scientific ...

Much of the U.S. uses single-stream recycling, where plastic, glass and paper go into one bin. Here’s what happens to that ...

In the coming months, two Ohio University students will watch their class project shoot into space and dock at the ...